Literature DB >> 30792036

Pattern, Stage, and Time of Recurrent Colorectal Cancer After Curative Surgery.

Salman Yousuf Guraya1.   

Abstract

Surgery remains the mainstay of curative treatment for colorectal cancer (CRC). Despite curative surgery, some patients experience cancer recurrence. However, the pattern, stage, and time of recurrent disease (RD) remain unknown. We aimed to determine the pattern and stage of RD after curative open and laparoscopic surgery for CRC. Databases were searched using selected keywords for clinical studies that analyzed the pattern, stage, and time of RD from CRC. A systematic protocol was used for data extraction, data synthesis, and interpretation of results. Of 455 publications retrieved from databases, 9 clinical studies were selected for this systematic review. There is substantial evidence that pulmonary recurrence is most commonly associated with rectal tumors, and multisite RD appears more frequently with right-sided CRC. RD from colon cancers predominantly appears early in liver, while recurrences from rectal cancer appear late in lungs. Approximately 30% to 50% of RD after curative resection of CRC occurs within the first 2 years; however, median time to recurrence is gradually increasing, particularly for patients with rectal cancers. Advanced primary CRC is significantly correlated with more locoregional and distant RD, with worse disease-free survival. There is a decrease in the 5-year incidence of RD that is associated with prolongation of time of RD for both locoregional and metastatic disease. The duration and design of postoperative follow-up protocols for recurrences from CRC should be tailored to site and stage of primary tumor, as rectal cancers demand longer surveillance times than colon cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Curative surgery; Locoregional recurrence; Recurrence after surgery

Mesh:

Year:  2019        PMID: 30792036     DOI: 10.1016/j.clcc.2019.01.003

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  22 in total

Review 1.  Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic Review.

Authors:  Phillip J Hsu; Khushboo Singh; Ankit Dhiman; Hunter D D Witmer; Chuan He; Oliver S Eng; Daniel V T Catenacci; Mitchell C Posner; Kiran K Turaga
Journal:  JCO Precis Oncol       Date:  2022-02

Review 2.  Health-Related Quality of Life of Patients Treated with Biological Agents and New Small-Molecule Drugs for Moderate to Severe Crohn's Disease: A Systematic Review.

Authors:  Hasan Aladraj; Mohamed Abdulla; Salman Yousuf Guraya; Shaista Salman Guraya
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

3.  5-fluorouracil treatment of patient-derived scaffolds from colorectal cancer reveal clinically critical information.

Authors:  Simona Salerno; Anders Ståhlberg; André Holdfeldt; Elinor Bexe Lindskog; Göran Landberg
Journal:  J Transl Med       Date:  2022-05-13       Impact factor: 8.440

4.  A novel CpG-methylation-based nomogram predicts survival in colorectal cancer.

Authors:  Xiaokang Wang; Danwen Wang; Jinfeng Liu; Maohui Feng; Xiongzhi Wu
Journal:  Epigenetics       Date:  2020-05-12       Impact factor: 4.528

5.  The utility of surveillance CT scans in a cohort of survivors of colorectal cancer.

Authors:  Jorja Braden; Prunella Blinman; Ashanya Malalasekera; Kim Kerin-Ayres; Jarrah Spencer; Natalie Southi; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2022-01-18       Impact factor: 4.442

6.  Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.

Authors:  Jinrong Qian; Lifeng Zeng; Xiaohua Jiang; Zhiyong Zhang; Xiaojiang Luo
Journal:  Med Sci Monit       Date:  2019-09-27

7.  LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer.

Authors:  Rui Tang; Junhong Chen; Mengtian Tang; Zhiqiang Liao; Lianqing Zhou; Jiarui Jiang; Yingbin Hu; QianJin Liao; Wei Xiong; Yanyan Tang; Shaolin Nie
Journal:  Int J Biol Sci       Date:  2019-11-08       Impact factor: 6.580

Review 8.  Function and mechanisms of microRNA-20a in colorectal cancer.

Authors:  Zheng Xiao; Shi Chen; Shujun Feng; Yukun Li; Juan Zou; Hui Ling; Ying Zeng; Xi Zeng
Journal:  Exp Ther Med       Date:  2020-01-08       Impact factor: 2.447

9.  Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.

Authors:  Yi Yang; Yujie Lu; Wen Jiang; Jinzhou Zhu; Su Yan
Journal:  World J Surg Oncol       Date:  2020-08-03       Impact factor: 2.754

10.  LINC00961 inhibits the migration and invasion of colon cancer cells by sponging miR-223-3p and targeting SOX11.

Authors:  Haixia Wu; Yuedi Dai; Dexiang Zhang; Xiaoyu Zhang; Zhiyun He; Xiaojun Xie; Chudong Cai
Journal:  Cancer Med       Date:  2020-02-11       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.